Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Dec 04, 2023

BUY
$96.41 - $126.61 $1,928 - $2,532
20 New
20 $2.07 Million
Q4 2022

May 11, 2023

SELL
$118.38 - $210.04 $710 - $1,260
-6 Closed
0 $0
Q3 2022

May 11, 2023

BUY
$118.07 - $194.18 $708 - $1,165
6 New
6 $902,000
Q3 2021

Aug 10, 2023

BUY
$221.9 - $484.47 $443 - $968
2 Added 0.83%
242 $83.5 Million
Q2 2021

Aug 10, 2023

SELL
$129.91 - $234.98 $16,238 - $29,372
-125 Reduced 34.25%
240 $56.4 Million
Q1 2021

Aug 10, 2023

BUY
$109.18 - $185.98 $39,850 - $67,882
365 New
365 $47.8 Million
Q4 2020

Jun 07, 2023

BUY
$65.74 - $169.86 $17,421 - $45,012
265 New
265 $27.7 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Tucker Asset Management LLC Portfolio

Follow Tucker Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tucker Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tucker Asset Management LLC with notifications on news.